GABBR2 and neoplasm: FCM for single-cell analysis in tumor tissue further confirmed that GB2 treatment elevated the portion of CD8+ T cells from 4.89% to 10.3% of CD45+ lymphocytes, indicating that GB2 recruited a significant number of CD8+ T cells into the tumor and promotes their migration to the interior (Figure 8B-C).